GPT and hepatitis A virus infection: Third, the irregular intervals of ALT monitoring, combined with the fact that HBV serological markers and HBV DNA viral load were typically only checked when ALT levels were elevated during everolimus treatment, could affect the accuracy of hepatitis timing and potentially lead to an underestimation of the HBVr risk associated with everolimus.